about
Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data.A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease.Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required?Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspects.Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4+ T cells partly via transforming growth factor-β1.Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.Patient and researcher perspectives on facilitating patient and public involvement in rheumatology research.Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis.Profound invariant natural killer T-cell deficiency in inflammatory arthritis.What are the dominant cytokines in early rheumatoid arthritis?The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy.Let's not fool ourselves. In RA, the ACR/EULAR remission criteria are not perfect!CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Patients With Untreated Early Arthritis: Implications for Causal Gene Identification.Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses.Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.Synovial tissue research: a state-of-the-art reviewBcl-3 in CD4+ T Cell-Mediated Rheumatoid Arthritis Pathogenesis: Comment on the Article by Meguro et alGenotyping in rheumatoid arthritis: a game changer in clinical management?Retrospective analysis of the role of serum vitamin D in early rheumatic diseasePrevalence and diagnostic outcome relating to vitamin D deficiency in new patients presenting to an early arthritis clinic over 12 monthsSerotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohortThe clinical utility of a rule for predicting rheumatoid arthritis in patients with early undifferentiated arthritis: Comment on the article by van der Helm-van Mil et alPatient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across EuropeMacrophage proliferation distinguishes 2 subgroups of knee osteoarthritis patientsExpression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis.Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patientsBetween a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinic
P50
Q28109583-A8F04F40-545A-43AC-A28C-DCEBA8940067Q31112066-3A20ABD6-A424-456F-BD7D-DCCF1F9E8882Q36094049-B1B17B79-B9D7-4952-B3BF-9A4F19EE40BDQ37690108-E67429A7-A6F1-4484-A098-7C066157B175Q38284201-15616848-BE20-4017-A69A-91CB4CEC5929Q38800903-16A3A1E1-A6BA-4B7F-A56F-AC99A39C0785Q38991972-98058164-7744-4000-BA0C-286A5B05930CQ40407272-CDC13C1F-B9E2-4DF7-80E1-90B74D845F6CQ40891825-8C60280E-A3F3-40BD-B05E-9EB2F282CEB0Q43696497-72636C9F-3DC3-4AF5-B20A-1B7CA318AF80Q47366363-8DE35714-2386-48B1-B2FD-05B2144D32FFQ47427257-19312835-7C1B-4A93-86E1-6D0032CD3F48Q48171918-3D585F70-4449-4CB9-AA04-085D4DC89277Q49376742-0FC609FB-F70F-4379-A2F6-B4E030841112Q50960730-A114CE4A-A57A-468C-BCD7-3F6A7C6BB77BQ55344794-CFC25A1E-9D81-4683-A6D3-6B3FDECB6C4AQ59041025-56A298E7-BF42-4D79-A1F3-5B3164AE598EQ60061978-6FBAF644-DA4F-4965-9F14-7664F2B7C1CDQ60061980-ECED2232-8BC3-4074-8C09-40526F82FB57Q60061981-DA52BCC8-F026-4C63-8068-7DCAB42D96EDQ60061987-D8A206C7-FADD-4543-868F-0E1823288654Q60061988-591C2834-6981-40B6-A767-EDF7303473E1Q60061995-B73C361F-B830-49A9-ACF1-56BD0C4D7837Q61307185-B90CC02C-4455-4A0B-A5F8-3145AE464506Q64261899-B3E320A7-58F2-4302-8B49-D8967B7B5FE3Q64967594-4E49FBDD-EC38-40A7-AFE3-81EA769A2B7DQ91502743-09B81EDB-1B69-4BAF-B381-1EA0B4271A6DQ92974083-E4A44AAF-53F4-43E0-BAF5-AE680407B2C8
P50
description
researcher ORCID 0000-0002-9909-8209
@en
wetenschapper
@nl
name
Arthur Pratt
@ast
Arthur Pratt
@en
Arthur Pratt
@nl
type
label
Arthur Pratt
@ast
Arthur Pratt
@en
Arthur Pratt
@nl
prefLabel
Arthur Pratt
@ast
Arthur Pratt
@en
Arthur Pratt
@nl
P106
P31
P496
0000-0002-9909-8209